MP-AzeFlu Allergen Chamber - Onset of Action Study

NCT03004131 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: Azelastine hydrochloride + fluticasone propionate nasal spray
DRUG: Placebos
DRUG: fluticasone propionate nasal spray + loratadine

Sponsor

MEDA Pharma GmbH & Co. KG